TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Bioglan AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
297,317
|
225,531
|
181,212 |
| Financial expenses |
675
|
913
|
803 |
| Earnings before taxes |
39,381
|
29,693
|
10,583 |
| EBITDA |
43,554
|
36,970
|
16,435 |
| Total assets |
284,048
|
229,226
|
188,846 |
| Current assets |
191,190
|
148,636
|
121,794 |
| Current liabilities |
119,072
|
95,405
|
78,199 |
| Equity capital |
164,976
|
133,821
|
110,647 |
| - share capital |
3,000
|
3,000
|
3,000 |
| Employees (average) |
113
|
102
|
101 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
58.1%
|
58.4%
|
58.6% |
| Turnover per employee |
2,631
|
2,211
|
1,794 |
| Profit as a percentage of turnover |
13.2%
|
13.2%
|
5.8% |
| Return on assets (ROA) |
14.1%
|
13.4%
|
6.0% |
| Current ratio |
160.6%
|
155.8%
|
155.7% |
| Return on equity (ROE) |
23.9%
|
22.2%
|
9.6% |
| Change turnover |
71,786
|
44,319
|
19,880 |
| Change turnover % |
32%
|
24%
|
12% |
| Chg. No. of employees |
11
|
1
|
7 |
| Chg. No. of employees % |
11%
|
1%
|
7% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.